Profil
Joshua Rosenblat is the founder of 1907 Foundation.
He is currently working as an Assistant Professor at the University of Toronto, a Clinical & Technical Advisor at iGan Partners, and as the Chief Medical & Scientific Officer at Braxia Scientific Corp.
He completed his undergraduate degree at the University of Toronto and his doctorate at the University of Western Ontario.
Postes actifs de Joshua Rosenblat
| Sociétés | Poste | Début |
|---|---|---|
| CHAMPIGNON BRANDS | Directeur Technique/Scientifique/R&D | 28/05/2021 |
iGan Partners
iGan Partners Investment ManagersFinance iGan Partners invests in companies located in Canada. The firm targets companies operating in the fields of healthcare technology, digital therapeutics, medical devices,AI- enabled MedTech and digital health sector. It provides financing for seed and early stage capital requirements. It also makes follow-on-investments. | Consultant / Advisor | - |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
1907 Foundation | Fondateur | - |
Formation de Joshua Rosenblat
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iGan Partners
iGan Partners Investment ManagersFinance iGan Partners invests in companies located in Canada. The firm targets companies operating in the fields of healthcare technology, digital therapeutics, medical devices,AI- enabled MedTech and digital health sector. It provides financing for seed and early stage capital requirements. It also makes follow-on-investments. | Finance |
Braxia Scientific Corp.
Braxia Scientific Corp. BiotechnologyHealth Technology Develops ketamine treatment and psychedelic medicine for mental health treatments | Health Technology |
1907 Foundation |
















